EUVIMEDEUVIMED entdecken
Crossref

Efficacy and Tolerability of Miltefosin for Childhood in Visceral leishmaniasis

Murshed MM

TMSS Medical College Journal (TMCJ) · 01.07.2019 · 13 (Number 02)

DOI: 10.62948/tmcj.2019.1302.06 ↗

Kurz gefasst

Fachartikel in der Zeitschrift TMSS Medical College Journal (TMCJ), online erschienen am 01.07.2019. Verfasst von Murshed MM.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bangladesh is a kala-azar endemic country. Previously Visceral leishmaniasis was treated with intravenous Sodium stibogluconate. But it was hazardous for the patients and associated with many adverse effects. So, doctors were searching for an oral antileishmanial drug. Miltefosin is an oral anticancer drug, but has an excellent antileishmanial activity.

Objective

To see the effectiveness and tolerability of Miltefosin for childhood Visceral leishmaniasis. Materials and Methods: This is a prospective type of descriptive study. Study setting and period: Department of Pediatrics, Rajshahi Medical College & Hospital. Rajshahi during September 2011 to February 2012. Study population: Patients of Visceral leishmaniasis admitted in Pediatrics department, Rajshahi Medical College & Hospital. Sample size: Forty four (44) Patients of Visceral leishmaniasis admitted in Pediatrics department, Rajshahi Medical College & Hospital.

Results

86.4% patients of childhood Visceral leishmaniasis were cured (evidenced by absence of LD body in splenic aspirate) with Oral Miltefosin at a dose of 2.5mg/kg/day in two divided dose in the morning and evening after meal for 28 days. 65.9% became afebrile in 1-6 days, 20.5% in 7-10 days and 13.6% in >10 days. Mean weight of the patients was increased from 22.5 kg to 23.2 kg. Very few adverse effects were noted. Most of them were gastrointestinal symptoms like, nausea (29.5%), vomiting (22.7%), diarrhea (18.2%) and 11.4% patients showed transient elevation of serum transaminases. But no patient needed to discontinue the treatment with Miltefosin.

Conclusion

This study indicates that Miltefosin is safe, well tolerable and highly effective for childhood Visceral leishmaniasis.

Zitieren

APA

MM, M. (2019). Efficacy and Tolerability of Miltefosin for Childhood in Visceral leishmaniasis. TMSS Medical College Journal (TMCJ), 13(Number 02). https://doi.org/10.62948/tmcj.2019.1302.06

Vancouver

MM M. Efficacy and Tolerability of Miltefosin for Childhood in Visceral leishmaniasis. TMSS Medical College Journal (TMCJ). 2019;13(Number 02). doi:10.62948/tmcj.2019.1302.06

BibTeX
@article{MM2019,
  author = {MM, Murshed},
  title = {Efficacy and Tolerability of Miltefosin for Childhood in Visceral leishmaniasis},
  journal = {TMSS Medical College Journal (TMCJ)},
  year = {2019},
  volume = {13},
  number = {Number 02},
  doi = {10.62948/tmcj.2019.1302.06}
}
Kostenlos starten →